BIOGNOSTIK was founded in 1991 as a technology-driven company, pursuing the development of medical diagnostics and therapeutic compounds, primarily based on the synthetic nucleic acids. Our research efforts center around the development of therapeutic antisense-oligonucleotides. In the course of our own research, Biognostik has developed and refined a number of proprietary techniques of our ANTISENSE oligonucleotides for the application in cultured cells and in vivo.
In response to a growing demand from the scientific community for specific, stable and non-toxic antisense-oligonucleotides, BIOGNOSTIK began offering some of its antisense compounds to researchers in basic science, medicine and industry in 1993.
The experience and the huge positive feedback from many of our customers was so encouraging that we decided to broaden our spectrum of targets to include many genes which play an important role in the regulation of cell growth, signal transduction and gene expression.
With our 2001/2002 catalogue, BIOGNOSTIK now offers the largest selection of ready-made antisense-oligonucleotides found anywhere. Based on our experience with using antisense-oligonucleotides in a wide variety of cultured and in vivo models, we have built up our reputation for expert technical and scientific support of our customers. Please do not hesitate to contact one of our experts for assistance in planning, set-up and evaluation of your own antisense experiments.
Further information: http://www.biognostik.com/